CVS Stops Selling Cold and Cough Products Containing Phenylephrine in Response to FDA Advisory Vote

CVS Health is pulling some over-the-counter medicines due to an FDA vote against the effectiveness of a certain ingredient.

CVS Health has announced that it will be removing certain over-the-counter medicines from its stores due to a recent vote by the Food and Drug Administration (FDA) questioning the effectiveness of a specific ingredient. Specifically, CVS will be pulling oral cough and cold products that contain phenylephrine as the sole active ingredient.

In a statement to CNN, a CVS spokesperson confirmed the decision, stating that the company will continue to sell other oral cough and cold products to meet consumer needs. The spokesperson also emphasized that CVS is aware of the FDA Advisory Committee's position on oral phenylephrine and will comply with the FDA's directions to ensure that the products they sell are in accordance with all laws and regulations.

Phenylephrine is a common ingredient found in various cough and cold medications, including popular brands such as Nyquil, Tylenol, Advil, Robitussin, Sudafed, and Benadryl, according to the American Hospital Association.

The FDA panel's vote on September 12 was unanimous in questioning the effectiveness of orally administered phenylephrine and stated that current data does not support the recommended dosage for this ingredient. However, the panel did not raise any safety concerns related to the use of oral phenylephrine. The FDA clarified this in a news release on September 14, emphasizing that advisory committees provide independent advice and recommendations, but the final decision rests with the agency itself. The FDA will carefully consider the advisory committee's input and the evidence before taking any action regarding the status of oral phenylephrine.

As the flu season begins in the United States, it is worth noting that the number of cases typically peaks between December and February. Additionally, health officials are also concerned about respiratory syncytial virus (RSV) and strongly encourage individuals to get vaccinated for both the flu and COVID-19.

In summary, CVS Health is proactively removing certain oral cough and cold products from its stores in response to the FDA's vote against the effectiveness of phenylephrine as the sole active ingredient. While CVS will continue to offer alternative products to meet consumer needs, they are committed to ensuring compliance with all laws and regulations based on the FDA's guidance. It is important for individuals to stay informed about the evolving recommendations from health officials and to prioritize vaccinations for both the flu and COVID-19 during this upcoming flu season.

Share With Others